Efficacy and Safety of Capecitabine for Triple-Negative Breast Cancer: A Meta-Analysis

por Xun, Xueqiong, Cao, Qinguang, Hong, Pan, Rai, Saroj, Zhou, Yeming, Liu, Ruikang, Hu, Huiyong
Publicado 2022

Adverse events of bevacizumab for triple negative breast cancer and HER-2 negative metastatic breast cancer: A meta-analysis

por Xun, Xueqiong, Ai, Jun, Feng, Fuhui, Hong, Pan, Rai, Saroj, Liu, Ruikang, Zhang, Baowen, Zhou, Yeming, Hu, Huiyong
Publicado 2023

Efficacy and safety of utidelone plus capecitabine in advanced first-line therapy for metastatic breast cancer: A multicenter real-world study

por Bi, Pingping, Wang, Xi, Liu, Rui, Li, Xiuqin, Wei, Shanrong, Zhao, Jiawen, Tan, Xin, Zhang, Fan, Mao, Qing, Zhang, Ying, Tang, Baoyan, Xun, Xueqiong, Guo, Rong, Zheng, Kai, Zhou, Shaoqiang, Tang, Shicong
Publicado 2023